Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Design, development, and validation of a strand-specific RT-qPCR assay for GI and GII human Noroviruses.

Wellcome open research

König KMK, Jahun AS, Nayak K, Drumright LN, Zibauer M, Goodfellow I, Hosmillo M.
PMID: 34708158
Wellcome Open Res. 2021 Sep 23;6:245. doi: 10.12688/wellcomeopenres.17078.1. eCollection 2021.

Human noroviruses (HuNoV) are the major cause of viral gastroenteritis worldwide. Similar to other positive-sense single-stranded RNA viruses, norovirus RNA replication requires the formation of a negative strand RNA intermediate. Methods for detecting and quantifying the viral positive or...

Cite
König KMK, Jahun AS, Nayak K, et al. Design, development, and validation of a strand-specific RT-qPCR assay for GI and GII human Noroviruses. Wellcome Open Res. 2021;6:245doi: 10.12688/wellcomeopenres.17078.1.
König, K. M. K., Jahun, A. S., Nayak, K., Drumright, L. N., Zibauer, M., Goodfellow, I., & Hosmillo, M. (2021). Design, development, and validation of a strand-specific RT-qPCR assay for GI and GII human Noroviruses. Wellcome open research, 6245. https://doi.org/10.12688/wellcomeopenres.17078.1
König, Katja Marie Kjara, et al. "Design, development, and validation of a strand-specific RT-qPCR assay for GI and GII human Noroviruses." Wellcome open research vol. 6 (2021): 245. doi: https://doi.org/10.12688/wellcomeopenres.17078.1
König KMK, Jahun AS, Nayak K, Drumright LN, Zibauer M, Goodfellow I, Hosmillo M. Design, development, and validation of a strand-specific RT-qPCR assay for GI and GII human Noroviruses. Wellcome Open Res. 2021 Sep 23;6:245. doi: 10.12688/wellcomeopenres.17078.1. eCollection 2021. PMID: 34708158; PMCID: PMC8506223.
Copy Download .nbib Format: NLM
Covering more Territory to Fight Resistance: Considering Nurses' Role in Antimicrobial Stewardship.

Journal of infection prevention

Edwards R, Drumright L, Kiernan M, Holmes A.
PMID: 21532974
J Infect Prev. 2011 Jan;12(1):6-10. doi: 10.1177/1757177410389627.

The potential contribution nurses can make to the management of antimicrobials within an in-patient setting could impact on the development of antimicrobial resistance (AMR) and healthcare associated infections (HCAIs). Current initiatives promoting prudent antimicrobial prescribing and management have generally...

Cite
Edwards R, Drumright L, Kiernan M, et al. Covering more Territory to Fight Resistance: Considering Nurses' Role in Antimicrobial Stewardship. J Infect Prev. 2011;12(1):6-10doi: 10.1177/1757177410389627.
Edwards, R., Drumright, L., Kiernan, M., & Holmes, A. (2011). Covering more Territory to Fight Resistance: Considering Nurses' Role in Antimicrobial Stewardship. Journal of infection prevention, 12(1), 6-10. https://doi.org/10.1177/1757177410389627
Edwards, R, et al. "Covering more Territory to Fight Resistance: Considering Nurses' Role in Antimicrobial Stewardship." Journal of infection prevention vol. 12,1 (2011): 6-10. doi: https://doi.org/10.1177/1757177410389627
Edwards R, Drumright L, Kiernan M, Holmes A. Covering more Territory to Fight Resistance: Considering Nurses' Role in Antimicrobial Stewardship. J Infect Prev. 2011 Jan;12(1):6-10. doi: 10.1177/1757177410389627. PMID: 21532974; PMCID: PMC3083718.
Copy Download .nbib Format: NLM
Establishing a Peer Support Program for Survivors of COVID-19: A Report From the Critical and Acute Illness Recovery Organization.

American journal of critical care : an official publication, American Association of Critical-Care Nurses

Hope AA, Johnson AA, McPeake J, Felt H, Sevin CM, Mikkelsen ME, Iwashyna TJ, Lassen-Greene C, Haines KJ, Agarwal S, Bakhru RN, Boehm LM, Butcher BW, Drumright K, Eaton TL, Hibbert E, Hoehn KS, Hornstein D, Imperato-Shedden H, Jackson JC, Kloos JA, Lewis A, Meyer J, Montgomery-Yates A, Rojas V, Schorr C, Wade D, Williams C.
PMID: 33566061
Am J Crit Care. 2021 Feb 15;e1-e5. doi: 10.4037/ajcc2021675. Epub 2021 Feb 15.

No abstract available.

Cite
Hope AA, Johnson AA, McPeake J, et al. Establishing a Peer Support Program for Survivors of COVID-19: A Report From the Critical and Acute Illness Recovery Organization. Am J Crit Care. 2021;e1-e5doi: 10.4037/ajcc2021675.
Hope, A. A., Johnson, A. A., McPeake, J., Felt, H., Sevin, C. M., Mikkelsen, M. E., Iwashyna, T. J., Lassen-Greene, C., Haines, K. J., Agarwal, S., Bakhru, R. N., Boehm, L. M., Butcher, B. W., Drumright, K., Eaton, T. L., Hibbert, E., Hoehn, K. S., Hornstein, D., Imperato-Shedden, H., Jackson, J. C., Kloos, J. A., Lewis, A., Meyer, J., Montgomery-Yates, A., Rojas, V., Schorr, C., Wade, D., & Williams, C. (2021). Establishing a Peer Support Program for Survivors of COVID-19: A Report From the Critical and Acute Illness Recovery Organization. American journal of critical care : an official publication, American Association of Critical-Care Nurses, e1-e5. https://doi.org/10.4037/ajcc2021675
Hope, Aluko A, et al. "Establishing a Peer Support Program for Survivors of COVID-19: A Report From the Critical and Acute Illness Recovery Organization." American journal of critical care : an official publication, American Association of Critical-Care Nurses vol. (2021): e1-e5. doi: https://doi.org/10.4037/ajcc2021675
Hope AA, Johnson AA, McPeake J, Felt H, Sevin CM, Mikkelsen ME, Iwashyna TJ, Lassen-Greene C, Haines KJ, Agarwal S, Bakhru RN, Boehm LM, Butcher BW, Drumright K, Eaton TL, Hibbert E, Hoehn KS, Hornstein D, Imperato-Shedden H, Jackson JC, Kloos JA, Lewis A, Meyer J, Montgomery-Yates A, Rojas V, Schorr C, Wade D, Williams C. Establishing a Peer Support Program for Survivors of COVID-19: A Report From the Critical and Acute Illness Recovery Organization. Am J Crit Care. 2021 Feb 15;e1-e5. doi: 10.4037/ajcc2021675. Epub 2021 Feb 15. PMID: 33566061; PMCID: PMC8364567.
Copy Download .nbib Format: NLM
HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort.

Journal of acquired immune deficiency syndromes (1999)

Crane HM, Drumright L.
PMID: 35015740
J Acquir Immune Defic Syndr. 2022 Feb 01;89:S10-S14. doi: 10.1097/QAI.0000000000002836.

BACKGROUND: Owing to ongoing improvements in antiretroviral therapy, people with HIV (PWH) are achieving near-normal lifespans with many surviving into middle and old age. Despite this success, PWH have a higher than expected risk of developing non-AIDS comorbidities, multimorbidity,...

Cite
Crane HM, Drumright L. HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort. J Acquir Immune Defic Syndr. 2022;89:S10-S14doi: 10.1097/QAI.0000000000002836.
Crane, H. M., & Drumright, L. (2022). HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort. Journal of acquired immune deficiency syndromes (1999), 89S10-S14. https://doi.org/10.1097/QAI.0000000000002836
Crane, Heidi M, and Drumright, Lydia. "HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort." Journal of acquired immune deficiency syndromes (1999) vol. 89 (2022): S10-S14. doi: https://doi.org/10.1097/QAI.0000000000002836
Crane HM, Drumright L. HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort. J Acquir Immune Defic Syndr. 2022 Feb 01;89:S10-S14. doi: 10.1097/QAI.0000000000002836. PMID: 35015740.
Copy Download .nbib Format: NLM
HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort.

Journal of acquired immune deficiency syndromes (1999)

Crane HM, Drumright L.
PMID: 35015740
J Acquir Immune Defic Syndr. 2022 Feb 01;89:S10-S14. doi: 10.1097/QAI.0000000000002836.

BACKGROUND: Owing to ongoing improvements in antiretroviral therapy, people with HIV (PWH) are achieving near-normal lifespans with many surviving into middle and old age. Despite this success, PWH have a higher than expected risk of developing non-AIDS comorbidities, multimorbidity,...

Cite
Crane HM, Drumright L. HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort. J Acquir Immune Defic Syndr. 2022;89:S10-S14doi: 10.1097/QAI.0000000000002836.
Crane, H. M., & Drumright, L. (2022). HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort. Journal of acquired immune deficiency syndromes (1999), 89S10-S14. https://doi.org/10.1097/QAI.0000000000002836
Crane, Heidi M, and Drumright, Lydia. "HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort." Journal of acquired immune deficiency syndromes (1999) vol. 89 (2022): S10-S14. doi: https://doi.org/10.1097/QAI.0000000000002836
Crane HM, Drumright L. HIV, Aging, and Comorbidities Research in Clinical Cohorts: 3 Lessons Learned Using Examples From the CNICS Cohort. J Acquir Immune Defic Syndr. 2022 Feb 01;89:S10-S14. doi: 10.1097/QAI.0000000000002836. PMID: 35015740; PMCID: PMC8751281.
Copy Download .nbib Format: NLM
Innovative tools for quality assessment: integrated quality criteria for review of multiple study designs (ICROMS).

Public health

Zingg W, Castro-Sanchez E, Secci FV, Edwards R, Drumright LN, Sevdalis N, Holmes AH.
PMID: 26704633
Public Health. 2016 Apr;133:19-37. doi: 10.1016/j.puhe.2015.10.012. Epub 2015 Dec 17.

OBJECTIVES: With the aim to facilitate a more comprehensive review process in public health including patient safety, we established a tool that we have termed ICROMS (Integrated quality Criteria for the Review Of Multiple Study designs), which unifies, integrates...

Cite
Zingg W, Castro-Sanchez E, Secci FV, et al. Innovative tools for quality assessment: integrated quality criteria for review of multiple study designs (ICROMS). Public Health. 2015;133:19-37doi: 10.1016/j.puhe.2015.10.012.
Zingg, W., Castro-Sanchez, E., Secci, F. V., Edwards, R., Drumright, L. N., Sevdalis, N., & Holmes, A. H. (2016). Innovative tools for quality assessment: integrated quality criteria for review of multiple study designs (ICROMS). Public health, 13319-37. https://doi.org/10.1016/j.puhe.2015.10.012
Zingg, W, et al. "Innovative tools for quality assessment: integrated quality criteria for review of multiple study designs (ICROMS)." Public health vol. 133 (2016): 19-37. doi: https://doi.org/10.1016/j.puhe.2015.10.012
Zingg W, Castro-Sanchez E, Secci FV, Edwards R, Drumright LN, Sevdalis N, Holmes AH. Innovative tools for quality assessment: integrated quality criteria for review of multiple study designs (ICROMS). Public Health. 2016 Apr;133:19-37. doi: 10.1016/j.puhe.2015.10.012. Epub 2015 Dec 17. PMID: 26704633.
Copy Download .nbib Format: NLM
Pediatric dog bite outcomes: infections and scars.

Trauma surgery & acute care open

Drumright B, Borg B, Rozzelle A, Donoghue L, Shanti C.
PMID: 32550268
Trauma Surg Acute Care Open. 2020 Jun 10;5(1):e000445. doi: 10.1136/tsaco-2020-000445. eCollection 2020.

BACKGROUND: There is little consensus on the management of dog bite victims. Few studies have examined long-term patient outcomes. This study was designed to evaluate two outcomes: infection and unfavorable scar formation.METHODS: A retrospective study of dog bite cases...

Cite
Drumright B, Borg B, Rozzelle A, et al. Pediatric dog bite outcomes: infections and scars. Trauma Surg Acute Care Open. 2020;5(1):e000445doi: 10.1136/tsaco-2020-000445.
Drumright, B., Borg, B., Rozzelle, A., Donoghue, L., & Shanti, C. (2020). Pediatric dog bite outcomes: infections and scars. Trauma surgery & acute care open, 5(1), e000445. https://doi.org/10.1136/tsaco-2020-000445
Drumright, Benjamin, et al. "Pediatric dog bite outcomes: infections and scars." Trauma surgery & acute care open vol. 5,1 (2020): e000445. doi: https://doi.org/10.1136/tsaco-2020-000445
Drumright B, Borg B, Rozzelle A, Donoghue L, Shanti C. Pediatric dog bite outcomes: infections and scars. Trauma Surg Acute Care Open. 2020 Jun 10;5(1):e000445. doi: 10.1136/tsaco-2020-000445. eCollection 2020. PMID: 32550268; PMCID: PMC7292034.
Copy Download .nbib Format: NLM
Superhydrophilic surfaces via polymer-SiO2 nanocomposites.

Langmuir : the ACS journal of surfaces and colloids

Dong H, Ye P, Zhong M, Pietrasik J, Drumright R, Matyjaszewski K.
PMID: 20825227
Langmuir. 2010 Oct 05;26(19):15567-73. doi: 10.1021/la102145s.

A novel procedure for the preparation of superhydrophilic surfaces is described. The method employs fabricating the surface from a mixture of silica nanoparticles (NPs) and polymers containing reactive trimethoxysilyl (TMOS) groups. Suitable polymers include quaternized poly(2-(dimethylamino)ethyl methacrylate) (PQDMAEMA) and...

Cite
Dong H, Ye P, Zhong M, et al. Superhydrophilic surfaces via polymer-SiO2 nanocomposites. Langmuir. 2010;26(19):15567-73doi: 10.1021/la102145s.
Dong, H., Ye, P., Zhong, M., Pietrasik, J., Drumright, R., & Matyjaszewski, K. (2010). Superhydrophilic surfaces via polymer-SiO2 nanocomposites. Langmuir : the ACS journal of surfaces and colloids, 26(19), 15567-73. https://doi.org/10.1021/la102145s
Dong, Hongchen, et al. "Superhydrophilic surfaces via polymer-SiO2 nanocomposites." Langmuir : the ACS journal of surfaces and colloids vol. 26,19 (2010): 15567-73. doi: https://doi.org/10.1021/la102145s
Dong H, Ye P, Zhong M, Pietrasik J, Drumright R, Matyjaszewski K. Superhydrophilic surfaces via polymer-SiO2 nanocomposites. Langmuir. 2010 Oct 05;26(19):15567-73. doi: 10.1021/la102145s. PMID: 20825227.
Copy Download .nbib Format: NLM
Utility of wound cultures in the management of open globe injuries: a 5-year retrospective review.

Journal of ophthalmic inflammation and infection

Drumright RT, Regan KA, Lin AL, Moroux MG, Iyer SSR.
PMID: 32009215
J Ophthalmic Inflamm Infect. 2020 Feb 03;10(1):5. doi: 10.1186/s12348-020-0196-5.

BACKGROUND: Endophthalmitis after open globe injury can be devastating to vision recovery. As treatment of endophthalmitis is often empiric, some surgeons may obtain cultures at presentation of trauma in anticipation of later infection. This study examines the usefulness of...

Cite
Drumright RT, Regan KA, Lin AL, et al. Utility of wound cultures in the management of open globe injuries: a 5-year retrospective review. J Ophthalmic Inflamm Infect. 2020;10(1):5doi: 10.1186/s12348-020-0196-5.
Drumright, R. T., Regan, K. A., Lin, A. L., Moroux, M. G., & Iyer, S. S. R. (2020). Utility of wound cultures in the management of open globe injuries: a 5-year retrospective review. Journal of ophthalmic inflammation and infection, 10(1), 5. https://doi.org/10.1186/s12348-020-0196-5
Drumright, Ryan T, et al. "Utility of wound cultures in the management of open globe injuries: a 5-year retrospective review." Journal of ophthalmic inflammation and infection vol. 10,1 (2020): 5. doi: https://doi.org/10.1186/s12348-020-0196-5
Drumright RT, Regan KA, Lin AL, Moroux MG, Iyer SSR. Utility of wound cultures in the management of open globe injuries: a 5-year retrospective review. J Ophthalmic Inflamm Infect. 2020 Feb 03;10(1):5. doi: 10.1186/s12348-020-0196-5. PMID: 32009215; PMCID: PMC6995799.
Copy Download .nbib Format: NLM
Cessation of ciprofloxacin prophylaxis in haemato-oncology patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Caldwell L, Bapat A, Drumright L, Lambourne J, Jimenez-England F, Aries J, Eccersley L, Hallam S, Montoto S, Oakervee H, Riches J, Agrawal S.
PMID: 34864924
Clin Infect Dis. 2021 Dec 04; doi: 10.1093/cid/ciab1000. Epub 2021 Dec 04.

No abstract available.

Cite
Caldwell L, Bapat A, Drumright L, et al. Cessation of ciprofloxacin prophylaxis in haemato-oncology patients. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab1000.
Caldwell, L., Bapat, A., Drumright, L., Lambourne, J., Jimenez-England, F., Aries, J., Eccersley, L., Hallam, S., Montoto, S., Oakervee, H., Riches, J., & Agrawal, S. (2021). Cessation of ciprofloxacin prophylaxis in haemato-oncology patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab1000
Caldwell, Louise, et al. "Cessation of ciprofloxacin prophylaxis in haemato-oncology patients." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab1000
Caldwell L, Bapat A, Drumright L, Lambourne J, Jimenez-England F, Aries J, Eccersley L, Hallam S, Montoto S, Oakervee H, Riches J, Agrawal S. Cessation of ciprofloxacin prophylaxis in haemato-oncology patients. Clin Infect Dis. 2021 Dec 04; doi: 10.1093/cid/ciab1000. Epub 2021 Dec 04. PMID: 34864924.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries